🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Applied BioCode Corporation (TPE:6598)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
20.80
-1.00 (-4.59%)
Nov 20, 2026, 1:30 PM CST

Applied BioCode Statistics

Total Valuation

Applied BioCode has a market cap or net worth of TWD 2.14 billion. The enterprise value is 1.67 billion.

Market Cap2.14B
Enterprise Value 1.67B

Important Dates

The next estimated earnings date is Thursday, March 11, 2027.

Earnings Date Mar 11, 2027
Ex-Dividend Date n/a

Share Statistics

Applied BioCode has 102.82 million shares outstanding.

Current Share Class 102.82M
Shares Outstanding 102.82M
Shares Change (YoY) n/a
Shares Change (QoQ) -0.03%
Owned by Insiders (%) 11.20%
Owned by Institutions (%) 6.76%
Float 71.37M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 2.94
PB Ratio 3.13
P/TBV Ratio 3.13
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 2.29
EV / EBITDA 214.38
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 6.12, with a Debt / Equity ratio of 0.07.

Current Ratio 6.12
Quick Ratio 4.64
Debt / Equity 0.07
Debt / EBITDA 5.91
Debt / FCF n/a
Interest Coverage -13.00

Financial Efficiency

Return on equity (ROE) is -5.07% and return on invested capital (ROIC) is -4.09%.

Return on Equity (ROE) -5.07%
Return on Assets (ROA) -3.33%
Return on Invested Capital (ROIC) -4.09%
Return on Capital Employed (ROCE) -5.36%
Weighted Average Cost of Capital (WACC) 7.56%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover 0.70
Inventory Turnover 1.46

Taxes

In the past 12 months, Applied BioCode has paid 238,000 in taxes.

Income Tax 238,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +1.22% in the last 52 weeks. The beta is 0.61, so Applied BioCode's price volatility has been lower than the market average.

Beta (5Y) 0.61
52-Week Price Change +1.22%
50-Day Moving Average 27.32
200-Day Moving Average 25.52
Relative Strength Index (RSI) 18.31
Average Volume (20 Days) 227,903

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Applied BioCode had revenue of TWD 728.39 million and -34.76 million in losses. Loss per share was -0.34.

Revenue728.39M
Gross Profit 446.18M
Operating Income -48.43M
Pretax Income -34.52M
Net Income -34.76M
EBITDA -14.42M
EBIT -48.43M
Loss Per Share -0.34
Full Income Statement

Balance Sheet

The company has 514.83 million in cash and 46.04 million in debt, with a net cash position of 468.80 million or 4.56 per share.

Cash & Cash Equivalents 514.83M
Total Debt 46.04M
Net Cash 468.80M
Net Cash Per Share 4.56
Equity (Book Value) 682.43M
Book Value Per Share 6.64
Working Capital 777.01M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -101.02 million and capital expenditures -9.51 million, giving a free cash flow of -110.53 million.

Operating Cash Flow -101.02M
Capital Expenditures -9.51M
Depreciation & Amortization 34.01M
Net Borrowing -18.99M
Free Cash Flow -110.53M
FCF Per Share -1.07
Full Cash Flow Statement

Margins

Gross margin is 61.26%, with operating and profit margins of -6.65% and -4.77%.

Gross Margin 61.26%
Operating Margin -6.65%
Pretax Margin -4.74%
Profit Margin -4.77%
EBITDA Margin -1.98%
EBIT Margin -6.65%
FCF Margin n/a

Dividends & Yields

Applied BioCode does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -1.63%
FCF Yield -5.17%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Applied BioCode has an Altman Z-Score of 4.92 and a Piotroski F-Score of 2.

Altman Z-Score 4.92
Piotroski F-Score 2